Correlation Between Hookipa Pharma and Gossamer Bio
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Gossamer Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Gossamer Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Gossamer Bio, you can compare the effects of market volatilities on Hookipa Pharma and Gossamer Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Gossamer Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Gossamer Bio.
Diversification Opportunities for Hookipa Pharma and Gossamer Bio
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Hookipa and Gossamer is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Gossamer Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gossamer Bio and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Gossamer Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gossamer Bio has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Gossamer Bio go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Gossamer Bio
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Gossamer Bio. But the stock apears to be less risky and, when comparing its historical volatility, Hookipa Pharma is 1.78 times less risky than Gossamer Bio. The stock trades about -0.22 of its potential returns per unit of risk. The Gossamer Bio is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 70.00 in Gossamer Bio on September 27, 2024 and sell it today you would earn a total of 14.00 from holding Gossamer Bio or generate 20.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Hookipa Pharma vs. Gossamer Bio
Performance |
Timeline |
Hookipa Pharma |
Gossamer Bio |
Hookipa Pharma and Gossamer Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hookipa Pharma and Gossamer Bio
The main advantage of trading using opposite Hookipa Pharma and Gossamer Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Gossamer Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gossamer Bio will offset losses from the drop in Gossamer Bio's long position.Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
Gossamer Bio vs. Fate Therapeutics | Gossamer Bio vs. Caribou Biosciences | Gossamer Bio vs. Karyopharm Therapeutics | Gossamer Bio vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |